The DOI matches its Crossref record; 604 of the 604 references it cites were found in a registry or an index.
Central role of mitochondria in drug-induced liver injury
Abstract
A frequent mechanism for drug-induced liver injury (DILI) is the formation of reactive metabolites that trigger hepatitis through direct toxicity or immune reactions. Both events cause mitochondrial membrane disruption. Genetic or acquired factors predispose to metabolite-mediated hepatitis by increasing the formation of the reactive metabolite, decreasing its detoxification, or by the presence of critical human leukocyte antigen molecule(s). In other instances, the parent drug itself triggers mitochondrial membrane disruption or inhibits mitochondrial function through different mechanisms. Drugs can sequester coenzyme A or can inhibit mitochondrial β-oxidation enzymes, the transfer of electrons along the respiratory chain, or adenosine triphosphate (ATP) synthase. Drugs can also destroy mitochondrial DNA, inhibit its replication, decrease mitochondrial transcripts, or hamper mitochondrial protein synthesis. Quite often, a single drug has many different effects on mitochondrial function. A severe impairment of oxidative phosphorylation decreases hepatic ATP, leading to cell dysfunction or necrosis; it can also secondarily inhibit ß-oxidation, thus causing steatosis, and can also inhibit pyruvate catabolism, leading to lactic acidosis. A severe impairment of β-oxidation can cause a fatty liver; further, decreased gluconeogenesis and increased utilization of glucose to compensate for the inability to oxidize fatty acids, together with the mitochondrial toxicity of accumulated free fatty acids and lipid peroxidation products, may impair energy production, possibly leading to coma and death. Susceptibility to parent drug-mediated mitochondrial dysfunction can be increased by factors impairing the removal of the toxic parent compound or by the presence of other medical condition(s) impairing mitochondrial function. New drug molecules should be screened for possible mitochondrial effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, chronic and/or binge alcohol, high fat diets, tobacco smoking, or certain hepatotoxic drugs can directly damage the mitochondrial ETC, producing greater amounts of ROS leaked from the ETS [24], [25], [26], [27].”
Citations
Cites
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,197
Mitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084
Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis
Li, H., Zhu, H., Xu, C.-J., & Yuan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81590-1 · Cited by 4,445
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317
Urano, F., Wang, X.-Z., Bertolotti, A., Zhang, Y.-H., Chung, P., Harding, H., & Ron, D. (2000) · Science · doi:10.1126/science.287.5453.664 · Cited by 3,081
Roles of CHOP/GADD153 in endoplasmic reticulum stress
Oyadomari, S., & Mori, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401373 · Cited by 2,879
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785 · cited 1×
“Genetic differences in CYP expression CYP isoenzymes are under genetic control, and hepatic levels of a given isoenzyme differ considerably in different people (Shimada et al., 1994).”
Background
Flagged first, then by citations
Research works printed but not linked: 33
- Albrecht H., 1995, J Inflamm, 45, 64
- Bedossa P., 1994, Hepatology, 19, 1262
- Brivet F. G., 1999, J Hepatol, 30, 364
- Carini R., 1995, Hepatology, 21, 1089
- Chabrol B., 1994, Eur J Pediatr, 153, 133
- Clarke L., 1989, Cancer Res, 49, 2344
- Cribb A. E., 1996, Adverse Drug React Toxicol Rev, 15, 9
- Curzio M., 1985, Int J Tissue React, 7, 137
- De la Iglesia F. A., 1974, Lab Invest, 4, 539
- Dutertre J. P., 1991, Eur J Gastroenterol Hepatol, 3, 953
- Dybing E., 1976, Mol Pharmacol, 12, 911
- Feigelson H. S., 1997, Cancer Res, 57, 1063
- Feigelson H. S., 1998, Cancer Res, 58, 585
- Grimbert S., 1995, Am J Physiol, 268, G107
- Itoh S., 1977, Acta Hepato-Gastroenterol, 24, 415
- Kent P. D., 2004, J Rheumatol, 31, 1727
- Lettéron P., 1997, Am J Physiol, 272, G1141
- Lillibridge J. H., 1997, Drug Metab Dispos, 24, 509
- Lucena MI, 2011, Gastroenterology
- Moult P. J., 1975, Q J Med, 44, 99
- Nass M. M., 1984, Cancer Res, 44, 2677
- Ohnishi T., 2005, Oncol Rep, 13, 485
- Pessayre D., 1980, Biochem Pharmacol, 29, 219
- Poon G. K., 2001, Drug Metab Dispos, 29, 1608
- 10.1001/jama.1988.03410210079041 · DOI
- Roy S., 1980, Res Commun Chem Pathol Pharmacol, 27, 507
- Susin S A., 1998, Biochim Biophys Acta, 15, 1
- 10.1097/00008571-200303000-00004 · DOI
- Wang M., 1998, Drug Metab Dispos, 26, 98
- Wen B., 2011, Drug Metab Dispos
- Werner S., 1996, Cancer Res, 56, 4391
- Yunis A. A., 1989, Am J Med, 87, N44
- Zhang Z., 1993, Am J Hum Genet, 52, 1111
Cited by
Sorted by citations
Items 101–200 of 277
Liu, C., Sekine, S., & Ito, K. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.04.010 · Cited by 32
Silva, F. S. G., Ribeiro, M. P. C., Santos, M. S., Rocha‐Pereira, P., Santos‐Silva, A., & Custódio, J. B. A. (2013) · Toxicology · doi:10.1016/j.tox.2013.01.020 · Cited by 31
Relationship between coumarin-induced hepatocellular toxicity and mitochondrial function in rats
Tanaka, Y., Fujii, W., Hori, H., Kitagawa, Y., & Ozaki, K. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.01.007 · Cited by 30
Mechanisms of Hepatic Cholestatic Drug Injury
Kolarić, T. O., Ninčević, V., Smolić, R., Smolić, M., & Wu, G. Y. (2019) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2018.00042 · Cited by 31
Do In Vitro Assays Predict Drug Candidate Idiosyncratic Drug-Induced Liver Injury Risk?
Kenna, J. G., & Uetrecht, J. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.082719 · Cited by 31
Kwan, R., Chen, L., Park, M.-J., Su, Z., Weerasinghe, S. V. W., Lee, W. M., Durkalski‐Mauldin, V. L., Fontana, R. J., & Omary, M. B. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.03.002 · Cited by 30
Effects of salvianolic acid B on liver mitochondria of rats with nonalcoholic steatohepatitis
Wang, Y., Kong, W.-Z., Jin, Q.-M., Chen, J., & Dong, L. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i35.10104 · Cited by 29
Mitochondrial dysfunction and mitochondrion-targeted therapeutics in liver diseases
Xiang, L., Shao, Y., & Chen, Y. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2021.1909051 · Cited by 29
Wang, Z., Yao, J., Guo, H., Sheng, N., Guo, Y., & Dai, J. (2022) · Environmental Science & Technology · doi:10.1021/acs.est.2c00957 · Cited by 26
Proposal of an in silico profiler for categorisation of repeat dose toxicity data of hair dyes
Nelms, M., Ates, G., Madden, J. C., Vinken, M., Cronin, M., Rogiers, V., & Enoch, S. J. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1277-8 · Cited by 27
Wang, L., Li, M.-D., Cao, P., Zhang, C., Huang, F., Xu, X., Liu, B., & Zhang, M. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.09.003 · Cited by 27
Ansari, M. A., Raish, M., Jardan, Y. A. B., Ahmad, A., Shahid, M., Ahmad, S. F., Haq, N., Khan, M. R., & Bakheet, S. A. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i7.592 · Cited by 26
Liu, Y., Guo, Z., Li, J., Li, A., & Huo, T. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113968 · Cited by 27
Lin, J., Peng, Y., Wang, S.-Y., Young, T.-H., Salter, D. M., & Lee, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121365 · Cited by 26
Preventing Drug-Induced Liver Injury: How Useful Are Animal Models?
Ballet, F. (2015) · Digestive Diseases · doi:10.1159/000374093 · Cited by 25
Inflammatory Stress Sensitizes the Liver to Atorvastatin-Induced Injury in ApoE-/- Mice
Wu, W., Zhao, L., Yang, P., Zhou, W., Li, B., Moorhead, J. F., Varghese, Z., Ruan, X. Z., & Chen, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159512 · Cited by 25
A High Dose of Isoniazid Disturbs Endobiotic Homeostasis in Mouse Liver
Li, F., Wang, P., Liu, K., Tarragó, M. G., Lu, J. L., Chini, E. N., & Ma, X. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.070920 · Cited by 25
Alorabi, M., Mohammed, D. S., Mostafa‐Hedeab, G., El-Sherbeni, S. A., Negm, W. A., Mohammed, A. I. A., Al-Kuraishy, H. M., Nasreldin, N., Alotaibi, S. S., Lawal, B., et al. (2022) · BioMed Research International · doi:10.1155/2022/4122166 · Cited by 27
Applications of In Silico Models to Predict Drug-Induced Liver Injury
Lin, J., Li, M., Mak, W. Y., Shi, Y., Zhu, X., Tang, Z., He, Q., & Xiang, X. (2022) · Toxics · doi:10.3390/toxics10120788 · Cited by 24
Mitochondrial dysfunction and apoptosis underlie the hepatotoxicity of perhexiline
Ren, Z., Chen, S., Seo, J., Guo, X., Li, D., Ning, B., & Guo, L. (2020) · Toxicology in Vitro · doi:10.1016/j.tiv.2020.104987 · Cited by 23
Characterization of drug-induced human mitochondrial ADP/ATP carrier inhibition
Baron, S. J., King, M. S., Kunji, E. R. S., & Schirris, T. J. J. (2021) · Theranostics · doi:10.7150/thno.54936 · Cited by 23
Hallinger, D. R., Lindsay, H. B., Friedman, K. P., Suarez, D. A., & Simmons, S. O. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa059 · Cited by 22
Lan, A., Guerbette, T., Andriamihaja, M., Magnin, B., Bordet, M., Ferron, P., Burel, A., Viel, R., Fromenty, B., Corlu, A., et al. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.06.007 · Cited by 23
Self-citationShirakawa, M., Sekine, S., Tanaka, A., Horie, T., & Ito, K. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.06.018 · Cited by 22
Sphingolipids and mitochondrial function, lessons learned from yeast
Spincemaille, P., Cammue, B. P. A., & Thevissen, K. (2014) · Microbial Cell · doi:10.15698/mic2014.07.156 · Cited by 23
A rapid mitochondrial toxicity assay utilizing rapidly changing cell energy metabolism
Sanuki, Y., Araki, T., Nakazono, O., & Tsurui, K. (2017) · The Journal of Toxicological Sciences · doi:10.2131/jts.42.349 · Cited by 22
Toxicidad hepática causada por medicamentos: revisión estucturada
Paniagua, A. C., Posada, L. M. C., & Amariles, P. (2017) · Revista Colombiana de Gastroenterología · doi:10.22516/25007440.177 · Cited by 28
Determinants of Lactic Acidosis in Acute Cyanide Poisonings
Baud, F. J., Haidar, M., Jouffroy, R., Raphalen, J., Lamhaut, L., & Carli, P. A. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003075 · Cited by 22
Takemura, A., Izaki, A., Sekine, S., & Ito, K. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.05.016 · Cited by 23
Liou, G., Hsieh, C.-C., Lee, Y., Li, P., Tsai, M., Li, C.-T., & Wang, S. (2021) · Antioxidants · doi:10.3390/antiox10030442 · Cited by 20
Donato, M. T., Gómez-Lechón, M. J., & Tolosa, L. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1271784 · Cited by 20
Hoogstraten, C. A., Lyon, J. J., Smeitink, J. A. M., Rüssel, F. G. M., & Schirris, T. J. J. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000568 · Cited by 19
GADD45α alleviates acetaminophen-induced hepatotoxicity by promoting AMPK activation
Li, C., Ming, Y., Wang, Z., Xu, Q., Yao, L., Xu, D., Tang, Y., Lei, X., Li, X., & Mao, Y. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2912-y · Cited by 19
van der Stel, W., Yang, H., Vrijenhoek, N. G., Schimming, J. P., Callegaro, G., Carta, G., Darici, S., Delp, J., Forsby, A., White, A., et al. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03160-7 · Cited by 20
Mitochondrial dysfunction in drug-induced hepatic steatosis: Recent findings and current concept
Borgne‐Sanchez, A., & Fromenty, B. (2025) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2025.102529 · Cited by 24
Self-citationNiacin prevents mitochondrial oxidative stress caused by sub-chronic exposure to methylmercury
Pereira, L. C., de Paula, E. S., Pazin, M., Carneiro, M. F. H., Grotto, D., Barbosa, F., & Dorta, D. J. (2018) · Drug and Chemical Toxicology · doi:10.1080/01480545.2018.1497045 · Cited by 18
Metabolic Comorbidities and Risk of Development and Severity of Drug-Induced Liver Injury
Li, X., Gao, P., & Niu, J. (2019) · BioMed Research International · doi:10.1155/2019/8764093 · Cited by 19
Carbon nanomaterials: fundamental concepts, biological interactions, and clinical applications
Chow, E. K., Gu, M., & Xu, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816662-8.00014-x · Cited by 19
Ccrn4l as a pre-dose marker for prediction of cisplatin-induced hepatotoxicity susceptibility
Hwang, D., Won, D., Shin, Y. S., Kim, S.-Y., Kang, B.-C., Lim, K., Che, J., Nam, K. T., & Yun, J.-W. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.01.003 · Cited by 18
Uetake, H., Sugihara, K., Muro, K., Sunaya, T., Horiuchi-Yamamoto, Y., & Takikawa, H. (2017) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2017.09.004 · Cited by 18
Chen, G., Chiu, H.-H., Lin, S., Tseng, Y. J., Tsai, S.-J., & Kuo, C. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.08.013 · Cited by 17
Monitoring the Effects of Pharmacological Reagents on Mitochondrial Morphology
Fu, D., & Lippincott‐Schwartz, J. (2018) · Current Protocols in Cell Biology · doi:10.1002/cpcb.45 · Cited by 17
Wu, T., Ye, J., Shao, C., Lin, Y., Wang, W., Feng, S., & Zhong, B. (2022) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000504 · Cited by 16
Hepatic metabolic adaptation in a murine model of glutathione deficiency
Chen, Y., Golla, S., García-Milian, R., Thompson, D. C., Gonzalez, F. J., & Vasiliou, V. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.02.015 · Cited by 16
Liepinsh, E., Zvejniece, L., Clemensson, L. E., Ozola, M., Vavers, E., Cirule, H., Korzh, S., Skuja, S., Groma, V., Brīvība, M., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16363 · Cited by 15
Lepule, K., Cordier, W., Steenkamp, P. A., Nell, M. J., & Steenkamp, V. (2019) · South African Journal of Botany · doi:10.1016/j.sajb.2019.01.033 · Cited by 15
In vitro screening of cell bioenergetics to assess mitochondrial dysfunction in drug development
Tilmant, K., Gerets, H. H. J., Ron, P. D., Hanon, É., Bento‐Pereira, C., & Atienzar, F. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.07.012 · Cited by 15
Moore, C. J., Holstege, C. P., & Papin, J. A. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010927 · Cited by 17
Li, G., Li, Q., Zhang, C., Yu, Q., Li, Q., Zhou, X., Yang, R., Yang, X., Liu, H., & Yang, Y. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1242711 · Cited by 15
Huang, Y., Zhang, Y., Wu, K., Tan, X., Lan, T., & Wang, G. (2024) · Molecules · doi:10.3390/molecules29112663 · Cited by 15
Kwong, S. P., Huang, Z., Ji, L., & Wang, C. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113873 · Cited by 14
Ikeyama, Y., Sato, T., Takemura, A., Sekine, S., & Ito, K. (2020) · Toxicology in Vitro · doi:10.1016/j.tiv.2020.104889 · Cited by 14
Identification of novel glutathione adducts of benzbromarone in human liver microsomes
Cho, N., Kobayashi, K., Yoshida, M., Kogure, N., Takayama, H., & Chiba, K. (2016) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2016.10.412 · Cited by 14
Mitochondrial DNA Somatic Mutation in Cancer
Kim, A. (2014) · Toxicological Research · doi:10.5487/tr.2014.30.4.235 · Cited by 13
Influence of Antibiotics on Functionality and Viability of Liver Cells In Vitro
Doß, S., Blessing, C., Haller, K., Richter, G., & Sauer, M. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44100317 · Cited by 13
Drug reactive metabolite-induced hepatotoxicity: a comprehensive review
Mahajan, P., Palkar, M. B., & Pingili, R. B. (2024) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2024.2332613 · Cited by 15
A Proteomics Study on the Mechanism of Nutmeg-Induced Hepatotoxicity
Xia, W., Cao, Z., Zhang, X., & Gao, L. (2021) · Molecules · doi:10.3390/molecules26061748 · Cited by 13
In Vitro Assessment of Mitochondrial Toxicity to Predict Drug-Induced Liver Injury
Porceddu, M., Buron, N., Rustin, P., Fromenty, B., & Borgne‐Sanchez, A. (2018) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-7677-5_14 · Cited by 13
Self-citationVrbanac, J., & Slauter, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85704-8.00010-4 · Cited by 12
Cordier, W., Steenkamp, P. A., & Steenkamp, V. (2019) · South African Journal of Botany · doi:10.1016/j.sajb.2019.03.001 · Cited by 12
Khalatbari, A., Aghazadeh, Z., & Ji, C. (2021) · Hepatology Communications · doi:10.1002/hep4.1887 · Cited by 12
RetractedIdiosyncratic Drug-Induced Liver Injury: Mechanisms and Susceptibility Factors
Stephens, C., Lucena, M. I., & Andrade, R. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64089-8 · Cited by 11
Xu, J., Xiong, A., Wang, X., Yan, X., Chen, Y., Ye, X., Wang, Z., Ding, L., & Yang, L. (2023) · Archives of Pharmacal Research · doi:10.1007/s12272-023-01460-3 · Cited by 12
Boran, T., Zengin, Ö. S., Şeker, Z., Akyıldız, A. G., Öztaş, E., & Özhan, G. (2023) · Toxicology Letters · doi:10.1016/j.toxlet.2023.11.005 · Cited by 11
Niazi, S. K. (2025) · Pharmaceuticals · doi:10.3390/ph18070951 · Cited by 11
Application of Systems Pharmacology to Explore Mechanisms of Hepatotoxicity
SHON, J., & Abernethy, D. R. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.167 · Cited by 11
Inhibition of ATP synthesis by fenbufen and its conjugated metabolites in rat liver mitochondria
Syed, M., Skonberg, C., & Hansen, S. H. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.11.013 · Cited by 11
Effects of the Nonsteroidal Anti-inflammatory Drug Celecoxib on Mitochondrial Function
Tatematsu, Y., Fujita, H., Hayashi, H., Yamamoto, A., Tabata, A., Nagamune, H., & Ohkura, K. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00527 · Cited by 11
Hepatotoxicity Due to Mitochondrial Injury
Lemasters, J. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-387817-5.00005-4 · Cited by 11
Subchronic dietary exposure to ethoxyquin dimer induces microvesicular steatosis in male BALB/c mice
Bernhard, A., Rasinger, J. D., Wisløff, H., Kolbjørnsen, Ø., Myrmel, L. S., Berntssen, M. H. G., Lundebye, A., Ørnsrud, R., & Madsen, L. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.06.005 · Cited by 11
Mechanism and regulation of mitophagy in liver diseases: a review
Liu, S., Wang, L., Zhu, L., Zhao, T., Han, P., Yan, F., Wang, X., Li, C., Wang, Z., & Yang, B. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1614940 · Cited by 14
REMAXOL: MECHANISMS OF ACTION AND APPLICATION IN REAL CLINICAL PRACTICE. Part II
Ilchenko, L. Y., & Оковитый, С. В. (2016) · The Russian Archives of Internal Medicine · doi:10.20514/2226-6704-2016-6-3-8-18 · Cited by 10
Ippolito, D., Maino, C., Vernuccio, F., Cannella, R., Inchingolo, R., Dezio, M., Faletti, R., Bonaffini, P. A., Gatti, M., & Sironi, S. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i5.834 · Cited by 9
Porreca, I., D’Angelo, F., Gentilcore, D., Carchia, E., Amoresano, A., Affuso, A., Ceccarelli, M., Luca, P. D., Esposito, L., Guadagno, F. M., et al. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-1067 · Cited by 9
Type B Lactic Acidosis Associated With Venlafaxine Overdose
Iragavarapu, C., Gupta, T., Chugh, S. S., Aronow, W. S., & Frishman, W. H. (2014) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000114 · Cited by 9
Brecklinghaus, T., Albrecht, W., Duda, J., Kappenberg, F., Gründler, L., Edlund, K., Marchan, R., Ghallab, A., Cadenas, C., Rieck, A., et al. (2022) · Toxicology Letters · doi:10.1016/j.toxlet.2022.08.006 · Cited by 10
Vrbanac, J., & Slauter, R. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387815-1.00002-2 · Cited by 9
Lee, Y., Choi, D., Cheon, M.-W., Kim, J. G., Kim, J.-S., Shin, M., Kim, H. R., & Youn, D.-H. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/3294273 · Cited by 8
Pharmacokinetic and toxicodynamic concepts in idiosyncratic, drug-induced liver injury
Roth, R. A., Kana, O. Z., Filipovic, D., & Ganey, P. E. (2022) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2022.2113379 · Cited by 9
Huang, R., Cai, Y., He, Y., Yu, Z., Zhao, L., Wang, T., Shangguan, X., Zhao, Y., Chen, Z., Chen, Y., et al. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2023.00399 · Cited by 8
Wang, J., Lu, F., Lü, F., Cao, C., Xiao, Y., Bao, W., & Wang, H. (2024) · Toxicology · doi:10.1016/j.tox.2024.153880 · Cited by 8
Liang, L., Li, F.-J., Liu, X., Mu, J.-K., Wang, X., Dong, J.-C., Zeng, L., Gu, W., Li, J., Yang, X., et al. (2019) · BioMed Research International · doi:10.1155/2019/5729263 · Cited by 8
Idiosyncratic Adverse Drug Reactions
Mak, A., & Uetrecht, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64242-3 · Cited by 8
Ikeyama, Y., Sato, T., Takemura, A., Sekine, S., & Ito, K. (2020) · Toxicology in Vitro · doi:10.1016/j.tiv.2020.104785 · Cited by 8
Peyre, L., de Sousa, G., Barcellini-Couget, S., Luzy, A., Zucchini-Pascal, N., & Rahmani, R. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.07.024 · Cited by 9
Zhang, P., Li, L., Sun, H., Zhang, Y., Zhang, G., Zhang, T., & Zeng, C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.575695 · Cited by 7
Role of respiratory uncoupling in drug-induced mitochondrial permeability transition
Sato, T., Takemura, A., & Ito, K. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115659 · Cited by 7
Piao, S., Lin, H., Xia, T., & Chen, W. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03798-5 · Cited by 7
Abou-Hadeed, A. H., Mohamed, A., hegab, D. M., & Ghoneim, M. H. (2021) · PubMed Central · doi:10.22092/ari.2021.356439.1844 · Cited by 7
Hepatotoxicity and Antioxidants: An overview
Fikry, E. M., & Ahmed, A. Y. (2019) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v9i3-s.3089 · Cited by 7
Vuppalanchi, R. (2016) · Springer eBooks · doi:10.1007/978-3-319-30103-7_25 · Cited by 7
Acylcarnitines as Translational Biomarkers of Mitochondrial Dysfunction
Beger, R. D., Bhattacharyya, S., Gill, P. S., & James, L. P. (2018) · doi:10.1002/9781119329725.ch24 · Cited by 7
Role of oxidative stress and endoplasmic reticulum stress in drug-induced liver injury
Wu, H., Bao, X., Gutierrez, A. H., Nevzorova, Y. A., & Cubero, F. J. (2023) · Exploration of Digestive Diseases · doi:10.37349/edd.2023.00020 · Cited by 8
Bridging the gap between old and new concepts in drug-induced liver injury
Fromenty, B. (2013) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2012.12.003 · Cited by 6
Self-citationUse of Primary Rat Hepatocytes for Prediction of Drug‐Induced Mitochondrial Dysfunction
Liu, C., Sekine, S., Song, B., & Ito, K. (2017) · Current Protocols in Toxicology · doi:10.1002/cptx.24 · Cited by 6
Tigecycline Induced Cholestatic Liver Injury: A Case Report
Jing, L., Kai, Z., Liqin, Z., & Yihe, L. (2018) · Journal of Infectious Diseases and Epidemiology · doi:10.23937/2474-3658/1510060 · Cited by 6
Structure–Activity Modeling of Mitochondrial Dysfunction
Enoch, S. J., Mellor, C. L., & Nelms, M. (2018) · doi:10.1002/9781119329725.ch3 · Cited by 6
Experimental evaluation of favipiravir (T-705)-induced liver and kidney toxicity in rats
Ülger, M., Turan, I. T., Si̇pahi̇, A., & Önder, G. Ö. (2025) · Food and Chemical Toxicology · doi:10.1016/j.fct.2025.115472 · Cited by 5
Role of the Adaptive Immune System in Idiosyncratic Drug-Induced Liver Injury
Uetrecht, J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-387817-5.00011-x · Cited by 6
Goldring, C. E., Norris, A. M., Kitteringham, N. R., Aleo, M. D., Antoine, D. J., Heslop, J. A., Howell, B. A., Ingelman‐Sundberg, M., Kia, R., Kamalian, L., et al. (2015) · Applied In Vitro Toxicology · doi:10.1089/aivt.2015.0001 · Cited by 5
Metadata
- Authors
- Pessayre, D., Fromenty, B., Berson, A., Robin, M.-A., Lettéron, P., Moreau, R., & Mansouri, A.
- Affiliations
- Inserm (FR)
- Corresponding author
- Pessayre, Dominique
- Venue
- Drug Metabolism Reviews
- Publisher
- Informa UK Limited
- Published
- 2012-01-30
- Volume
- 44
- Issue
- 1
- Pages
- 34-87
- ISSN
- 0360-2532 (ISSN-L)
- 1097-9883
- OpenAlex
- W2076781542
- Cited by
- 277
- References
- 604
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 11 · 2023: 21 · 2022: 22 · 2021: 31 · 2020: 16 · 2019: 15 · 2018: 26 · 2017: 19 · 2016: 21 · 2015: 26 · 2014: 23 · 2013: 13 · 2012: 2
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Metabolism Reviews (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- drug-induced liver injury, mitochondrial dysfunction, reactive drug metabolites, mitochondrial membrane disruption, oxidative phosphorylation, ATP synthase inhibition, mitochondrial DNA damage, lactic acidosis, hepatic steatosis, steatosis, lipid peroxidation, human leukocyte antigen, genetic susceptibility, drug safety testing
- MeSH terms
- DNA, Mitochondrial, Pharmaceutical Preparations, Fatty Liver, Humans, Immune System, Liver, Mitochondria, Liver, Oxidation-Reduction, Reactive Oxygen Species, Cell Respiration, Mitochondrial Proteins, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review